ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,140Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 1111

$1.42M Total Retail Price of All Prescriptions

Rank: 15 out of 1111

949 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 949 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 949 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 20,082 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,695 1,192 S3 1 1
OMEPRAZOLE 832 622 2 4
TRAMADOL HCL 694 489 3 13
FUROSEMIDE 621 551 4 6
PRAVASTATIN SODIUM 603 482 5 17
LISINOPRIL 509 421 6 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 495 394 7 23
LEVOTHYROXINE SODIUM 493 399 8 3
AMLODIPINE BESYLATE 468 424 9 7
POTASSIUM CHLORIDE 465 417 10 9
METFORMIN HCL 442 337 11 8
ZOLPIDEM TARTRATE 420 266 12 16
CITALOPRAM HBR 415 300 13 14
WARFARIN SODIUM 386 340 14 19
SIMVASTATIN 380 336 15 5
MELOXICAM 375 286 16 18
ATORVASTATIN CALCIUM 351 288 17 15
METOPROLOL SUCCINATE 327 275 18 20
METOPROLOL TARTRATE 325 267 19 12
PAROXETINE HCL 325 277 19 55
DICLOFENAC SODIUM 305 230 21 108
NEXIUM 301 231 22 26
GABAPENTIN 290 212 23 10
DONEPEZIL HCL 281 275 24 25
CARVEDILOL 235 163 25 21
TAMSULOSIN HCL 234 201 26 28
CIPROFLOXACIN HCL 228 182 27 58
PRAMIPEXOLE DIHYDROCHLORIDE 225 185 28 186
TOPIRAMATE 206 95 29 177
ALLOPURINOL 191 145 30 36
TRAZODONE HCL 188 121 31 32
DOXYCYCLINE HYCLATE 180 127 32 113
CYMBALTA 171 70 33 40
NAMENDA 168 165 34 31
SULFAMETHOXAZOLE-TRIMETHOPRIM 166 97 35 71
PREDNISONE 165 130 36 48
PANTOPRAZOLE SODIUM 161 141 37 50
CLOPIDOGREL 156 131 38 30
SINGULAIR 153 119 39 112
LOSARTAN POTASSIUM 149 135 40 34
AMITRIPTYLINE HCL 147 132 R 41 64
LIPITOR 141 119 42 116
GLIMEPIRIDE 139 111 43 61
AMOXICILLIN 138 95 44 131
LEVOFLOXACIN 137 107 45 88
PROAIR HFA 136 91 46 38
AMOX TR-POTASSIUM CLAVULANATE 135 103 47 141
ADVAIR DISKUS 131 104 48 43
CYCLOBENZAPRINE HCL 128 75 R 49 37
METFORMIN HCL ER 127 81 50 84
DIOVAN 126 102 51 51
AZITHROMYCIN 124 93 52 39
SPIRIVA 118 92 53 53
GLIPIZIDE 118 76 53 57
ALENDRONATE SODIUM 116 101 55 35
PLAVIX 116 95 55 49
HYDROCHLOROTHIAZIDE 116 95 55 11
TRIAMTERENE-HCTZ 115 88 58 80
FLUTICASONE PROPIONATE 115 66 58 27
CRESTOR 112 85 60 33
CELEBREX 111 96 61 81
OXYBUTYNIN CHLORIDE 110 93 62 110
CLONIDINE HCL 108 77 63 42
TRIAMCINOLONE ACETONIDE 105 79 64 128
CEPHALEXIN 104 84 65 89
METOLAZONE 96 80 66 162
SYNTHROID 95 72 67 63
PROMETHAZINE HCL 94 75 R 68 69
KLOR-CON M10 93 88 69 144
LACTULOSE 92 75 70 166
MONTELUKAST SODIUM 92 74 70 206
NITROSTAT 91 80 72 200
ACTOS 90 73 73 98
ATENOLOL 89 73 74 22
RANITIDINE HCL 88 83 75 29
LOSARTAN-HYDROCHLOROTHIAZIDE 88 80 75 72
TIZANIDINE HCL 87 43 77 91
GLYBURIDE 87 54 R 77 59
LYRICA 87 50 77 62
ESCITALOPRAM OXALATE 85 74 80 78
FLUCONAZOLE 82 60 81 195
KLOR-CON M20 82 72 81 79
GEMFIBROZIL 82 35 81 92
VENLAFAXINE HCL 79 50 84 191
SUCRALFATE 78 57 85 125
ROPINIROLE HCL 77 71 86 68
COMBIVENT 77 68 86 129
BUPROPION XL 77 30 86 210
DIVALPROEX SODIUM 75 55 89 82
SPIRONOLACTONE 75 58 89 83
ESTRADIOL 73 52 R 91 102
PROPRANOLOL HCL 73 59 91 124
LANTUS 72 47 93 46
GLIPIZIDE ER 72 72 93 99
AMIODARONE HCL 70 60 95 145
ALPRAZOLAM 69 44 96 220
INSULIN SYRINGE 69 53 96 167
ISOSORBIDE MONONITRATE ER 69 68 96 73
GLYBURIDE-METFORMIN HCL 69 65 R 96 187
ENALAPRIL MALEATE 68 57 100 56
SULINDAC 65 57 101 217
TERAZOSIN HCL 65 56 101 127
GLIPIZIDE XL 65 65 101 211
IBUPROFEN 64 36 104 66
METOCLOPRAMIDE HCL 63 47 105 130
BENICAR 62 58 106 227
HYDROXYZINE HCL 62 31 R 106 159
TRIAMTERENE-HYDROCHLOROTHIAZID 61 39 108 230
TORSEMIDE 61 45 108 118
BISOPROLOL-HYDROCHLOROTHIAZIDE 61 47 108 143
POLYETHYLENE GLYCOL 3350 59 46 111 45
TRICOR 59 33 111 157
ZETIA 59 50 111 109
MUPIROCIN 59 49 111 154
DETROL LA 57 53 115 139
ONDANSETRON HCL 55 48 116 246
EXELON 53 53 117 121
LEXAPRO 52 37 118 208
ALBUTEROL SULFATE 51 50 119 136
RISPERIDONE 51 30 119 60
DIGOXIN 51 36 119 47
NOVOLIN 70-30 51 45 119 262
HUMULIN 70-30 50 38 123 251
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.